
Showing 161 - 180 of 290 results
Air pollution sampler installation in Papua New Guinea

Role at ANSTO
New global, first-of-a-kind ANSTO Synroc facility
A new nuclear medicine waste processing facility that showcases ANSTO Synroc technology is under construction.
The world’s best radon detector just got smaller
The need for a smaller, more transportable version of ANSTO’s 1500-litre atmospheric radon-222 monitor, and with a calibration traceable to the International System of Units, prompted the team to develop a 200-litre radon monitor that would meet those needs.
ANSTO fights cancer
Commitment to undertake health research.
Breaking the mould: Leadership announcement
Dr Ceri Brenner appointed new leader of the Centre for Accelerator Science
Progress on organic thin films for solar cells
Modifications to promising novel non-fullerene small molecule acceptor in organic thin film for solar cells demonstrates improved power conversion efficiency.
National Volunteer Week 2014: Part two
Black carbon detection technology launched commercially
The Multi-wavelength absorption black carbon instrument (MABI), a technology designed and built at ANSTO to measure black carbon in the atmosphere is now commercially available from Thomson Environmental Systems.
ANSTO to host 12th International Conference on Hot Isostatic Pressing

Visiting Australia

Visiting Australia - ANSTO-HZB Neutron Training Course 2024
New partnership and nuclear techniques to aid cancer research
International research reveals significance of human fossil methane contribution
A team of researchers including the University of Rochester, CSIRO and ANSTO has found methane emissions from human fossil sources have been greatly underestimated.

Information about ANSTO’s COVID-19 Rapid Antigen Test Program
Information about ANSTO’s COVID-19 Rapid Antigen Test Program
ANSTO scientists share Australian research with students on World Environment Day
Synchrotron-studied protein sheds light on Parkinson’s, stomach cancer, melanoma
Collaboration across the Tasman has enabled Australian and New Zealand researchers and scientists to shed light on a protein involved in diseases such as Parkinson’s disease, gastric cancer and melanoma.